Your cart is currently empty!
Advice to Feed Babies Peanuts Early and Often Helped 60,000 Kids Avoid Allergies, Study Finds

For decades, pediatricians gave parents the same advice: keep peanuts away from babies. Wait until age three, they said. Playing it safe meant avoiding the risk of allergic reactions. But what seemed like caution turned out to be exactly the wrong approach.
A quiet revolution in infant feeding guidelines began nearly 10 years ago. Now, new research reveals just how many young lives were changed because of it. Doctors can measure the impact in numbers that matter: tens of thousands of children who never developed a potentially deadly food allergy.
Recent findings published in the medical journal Pediatrics show that roughly 60,000 children have avoided developing food allergies since 2015. Among them, about 40,000 were spared from peanut allergies specifically. Researchers tracked this shift by analyzing electronic health records from dozens of pediatric practices across the United States.
Dr. David Hill, an allergist and researcher at Children’s Hospital of Philadelphia, led the study. His team examined diagnoses of food allergies in young children before, during, and after new guidelines emerged. What they found offers rare proof that changing medical practice can produce measurable public health benefits.
How Everything Changed in 2015

Before 2015, conventional medical wisdom told parents to delay introducing allergenic foods. Peanuts, eggs, milk, and other common allergens were considered too risky for babies and toddlers. Waiting until a child turned three seemed like the safest bet.
Gideon Lack at King’s College London suspected otherwise. His groundbreaking Learning Early About Peanut Allergy trial, known as LEAP, challenged decades of accepted practice. Lack and his colleagues showed that introducing peanut products during infancy reduced the future risk of developing food allergies by more than 80 percent.
Later analysis revealed that protection persisted in about 70 percent of children into adolescence. Results immediately sparked new guidelines urging early introduction of peanuts. Medical organizations began recommending that caregivers introduce the allergen to infants starting as early as four months.
Numbers from the recent study show the timeline of change. Peanut allergies in children ages zero to three declined by more than 27 percent after guidance for high-risk kids arrived in 2015. Rates dropped by more than 40 percent after recommendations expanded in 2017.
Yet overall food allergy rates continue rising in the United States. About eight percent of children face food allergies today, including more than two percent with a peanut allergy. Success in preventing peanut allergies hasn’t solved the broader problem, but it demonstrates what’s possible when science changes practice.
Why Peanuts Trigger Such Severe Reactions

Peanut allergy develops when the body’s immune system makes a critical error. Instead of recognizing peanut proteins as harmless, the immune system identifies them as dangerous invaders. Cells release chemicals that trigger allergic symptoms ranging from mild hives to severe respiratory distress.
In worst-case scenarios, exposure leads to anaphylaxis. Blood pressure drops. Dizziness sets in. Breathing becomes difficult or impossible. Without quick treatment with epinephrine, anaphylaxis can turn fatal.
Parents of children with peanut allergies live with constant vigilance. Reading every food label becomes routine. Restaurant meals require detailed conversations with servers and chefs. Schools must implement strict policies. An EpiPen stays within reach at all times.
Preventing these allergies from developing in the first place offers obvious benefits. Children gain the freedom to eat normally. Parents experience less anxiety. Schools face fewer restrictions. But translating research findings into widespread practice proved harder than expected.
When Knowledge Doesn’t Equal Action

Guidelines changed. Science supported early introduction. Yet many doctors remained hesitant.
Surveys found that only about 29 percent of pediatricians and 65 percent of allergists followed the expanded guidance issued in 2017. Confusion and uncertainty about the best methods led to delays. Medical experts and parents questioned whether the practice could work outside tightly controlled clinical trials.
Some pediatricians worried about recommending something that seemed counterintuitive. Parents expressed concerns about giving babies a food that might trigger severe reactions. Without clear protocols and consistent messaging, adoption lagged.
A separate clinical trial called iREACH set out to close that gap. Researchers at 30 pediatric practices tested whether specific interventions could improve doctors’ adherence to guidelines. Half of the practices received clinician education, a clinical decision support tool embedded into electronic health record systems, and visual aids. Control practices received nothing.
Results showed dramatic differences. Among low-risk infants with no eczema, mild eczema, or moderate eczema and no egg allergy, intervention clinicians gave proper guidance 83.7 percent of the time. Control clinicians managed only 34.7 percent adherence.
Even among high-risk infants with severe eczema or egg allergy, intervention clinicians performed better. They followed guidelines 26.8 percent of the time compared to 10.4 percent in control practices. While high-risk adherence remained lower overall, the improvement suggested that better tools and education could help.
Chantelle Velmont experienced the confusion firsthand. As a Toronto mother, she knew about early allergen introduction for her son, now seven months old. Yet nobody made it seem urgent. Her pediatrician didn’t mention the importance at her son’s four-month appointment.
Velmont finally tried giving her son a peanut product at 5½ months. His lips swelled right away. A rash appeared. Doctors later diagnosed allergies to both peanuts and eggs. Now Velmont carries an EpiPen everywhere.
“It’s definitely something I’m nervous about,” she said. Velmont wishes prenatal classes and medical professionals gave clearer, simpler guidance about introducing allergens. Information floods the internet, but sorting through recipes and advice from parent influencers feels overwhelming.
Her experience highlights a gap between research and implementation. Knowing that early introduction helps doesn’t guarantee parents receive proper instruction on timing and methods.
Tiffany Leon took a different path. As a registered dietician and director at Food Allergy Research & Education, Leon introduced peanuts and other allergens early to her sons James, now four, and Cameron, two.
Leon’s mother initially reacted with shock. Feeding babies such foods before age three contradicted everything she’d learned as a parent. Leon explained how the science evolved and what evidence now supports.
“As a dietician, I practice evidence-based recommendations. So when someone told me, ‘This is how it’s done now, these are the new guidelines,’ I just though, OK, well, this is what we’re going to do,” Leon said.
Current Recommendations and Practical Methods

Updated guidance from 2021 calls for introducing peanuts and other major food allergens between four and six months. No prior screening or testing is necessary for most infants. Parents should consult pediatricians about any specific concerns or questions.
Starting early matters, but consistency matters more. Dr. Derek Chu, a professor of medicine at McMaster University and chair in allergy, recommends that parents introduce food allergens early, often, and consistently once babies are developmentally ready within that four to six-month window.
Methods need not be complicated. Thin peanut butter with breast milk, formula, or water. Mix small amounts with puree. Start with little tastes and gradually increase amounts. Babies don’t need large quantities. Regular, repeated exposure helps the immune system learn to tolerate these proteins safely.
Recommendations extend beyond peanuts. Dairy, soy, wheat, sesame, egg, fish, shellfish, and tree nuts all deserve early introduction using similar approaches. Parents who introduce one allergen successfully should continue with others.
Risk of life-threatening reactions remains extremely low according to Food Allergy Canada. Still, parents should watch for warning signs during first introductions. Swelling, widespread hives, or breathing symptoms require immediate medical attention.
Chu offers reassurance alongside his recommendations. Parents can introduce allergens safely when they follow proper methods. Baby steps and repetition remain essential for infant development, just like any other milestone.
Evidence Shows Guidelines Work
Data from Hill’s study came from a subset of participating practice sites. Results may not represent the entire United States pediatric population perfectly. Yet patterns emerged clearly enough to conclude.
Ruchi Gupta, a child allergy expert at Northwestern University who wrote commentary accompanying the study, noted that the research offers “promising evidence that early allergen introduction is not only being adopted but may be making a measurable impact.”
Advocacy groups celebrated the findings. Sung Poblete, chief executive of Food Allergy Research & Education, said the research reinforces existing knowledge while highlighting an opportunity to reduce peanut allergy incidence and prevalence nationwide.
About 33 million people in the United States live with food allergies. Each case prevented means one less person facing daily challenges, medical costs, and potentially life-threatening situations.
Wide dissemination of interventions like those tested in the iREACH trial could amplify results. Getting all pediatricians on board with current guidelines might prevent tens of thousands of additional cases. Electronic health record prompts, clear educational materials, and consistent messaging from medical authorities all help.
Gaps That Need Closing

Despite progress, obstacles remain. Many pediatricians still don’t follow guidelines consistently. Parents often lack clear information about when and how to introduce allergens. Confusion persists even among families who want to follow best practices.
Education needs to reach expecting parents before babies arrive. Prenatal classes could cover allergen introduction alongside other feeding topics. Pediatricians need better tools and training to deliver consistent guidance at well-child visits.
Research must continue examining why overall food allergy rates keep climbing even as peanut allergies decline. Scientists need to understand what drives allergies to other foods and whether early introduction helps with all allergens equally.
Hill’s study demonstrates what’s possible when rigorous science translates into public health action. Guidelines based on solid evidence can change outcomes for thousands of families. But only if those guidelines reach doctors, parents, and caregivers who need them most.
A decade after LEAP changed medical thinking about infant feeding, progress continues. Sixty thousand children who might have developed food allergies didn’t. Forty thousand avoided peanut allergies specifically. Each number represents a child who can eat birthday cake without fear, attend school without restrictions, and live without carrying emergency medication everywhere.
Medical science rarely offers such clear wins. When it does, the next challenge becomes making sure everyone benefits.
